大规模网络动态的catecholaminergic调制与皮层状连接的重新配置有关
Justine A Hill1, Cole Korponay2,3, Betty Jo Salmeron1
1Biomedical Research Center, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland, USA.
Human brain mapping
|December 12, 2024
概括
甲基化物和皮醇改变了大脑网络的动态. 甲基化甲基化
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 认知科学 认知科学
背景情况:
- 大规模的大脑网络功能对认知至关重要.
- 大脑网络动态,神经化学和神经电路之间的关系尚未完全理解.
- 向甲基胺的药物治疗方法,如甲基胺和利,被广泛使用,但它们对大脑网络的确切影响需要进一步阐明.
研究的目的:
- 为了研究甲基化物和利对大规模大脑网络时间动态的影响.
- 检查药物诱导的网络动态变化和皮质前皮层连接的变化之间的关系.
- 了解这些药物疗法如何影响网络和电路层面上的大脑功能.
主要方法:
- 休息状态功能磁共振成像 (fMRI) 用于评估59名健康个体的大脑网络动态.
- 参与者在一个随机的,双盲的,受控的设计中接受了甲基 (20毫克),二醇 (2毫克) 或安慰剂.
- 分析了网络时间动态的变化,并与药物诱导的皮质干连接性改变相关联.
主要成果:
- 甲基酸盐显著增加了默认模式网络 (DMN) 和背部注意网络 (DAN) 状态的时间,同时减少了前对对面网络状态的时间.
- 利增加了在感官运动DMN状态中的时间.
- 甲基酸盐对网络动态的变化大小与皮质干连接的变化相关;利对这种连接没有影响.
结论:
- 甲基胺增强了参与注意力的大脑网络的参与,与其已知的效果一致.
- 药物疗法可以通过修改皮质前皮层连接来改变大规模的大脑网络动态.
- 这些发现提高了对大脑网络功能的理解,并可能根据网络层面的影响来告知临床药物使用.
相关概念视频
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:27Adrenergic Neurons: Neurotransmission
3.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.4K
01:21Drugs Affecting Neurotransmitter Release or Uptake
947
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
947
01:26Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
01:29Excitatory and Inhibitory Effects of Neurotransmitters
9.8K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.8K